In this special LipidCurious Inspiration episode, Dr. Vishnu Priya Pulipati, MD, FACE, DiplABCL, sits down with legendary lipid educator Dr. Thomas Dayspring, MD, FACP, FNLA, for a conversation beyond guidelines and numbers. Together, they explore the personal stories, career pivots, and defining moments that shaped a five-decade journey in medicine and lipidology. From evolving clinical passions to the power of teaching and lifelong curiosity, this episode is a reflective look at sustaining purpose and inspiration in a long career, especially when the spark needs reigniting.

Download the free LipidCurious Starter Kit here
Questions or feedback? hello@lipidcurious.com

Disclaimer: This podcast is intended for educational purposes for clinicians and healthcare professionals. It does not provide medical advice, establish a physician–patient relationship, or replace individualized clinical judgment. The opinions expressed are those of the creator and do not represent the views of any affiliated institutions or organizations.

ASCVD prevention isn’t about numbers; it’s about extending healthy years. Treat the right individual, at the right time, with the right intensity, and you give them more shared birthdays, more anniversaries, and more ordinary Tuesday dinners with the person they love. In Part 3 of the LipidCurious ASCVD Risk Stratification mini-series, we move from categorizing risk to taking action. Because risk scores don’t prevent events, decisions do.

In this episode, we cover:

1. What treatment targets are we actually aiming for?
2. How to choose LDL-C-lowering therapies strategically?
3. What does the future of ASCVD prevention look like?

Bonus: An easy-to-follow visual guide to help you navigate ASCVD Risk Stratification.

Want a companion resource? Download the free LipidCurious Starter Kit here
Questions or feedback? hello@lipidcurious.com

Join the Learn at Pinnacle app ⁠to earn FREE CE Credit for listening to this episode!

Disclaimer: This podcast is intended for educational purposes for clinicians and healthcare professionals. It does not provide medical advice, establish a physician–patient relationship, or replace individualized clinical judgment. The opinions expressed are those of the creator and do not represent the views of any affiliated institutions or organizations.

ASCVD risk stratification gets messy fast—especially when calculators, risk enhancers, and coronary calcium scores all compete for attention. In Part 2 of the LipidCurious ASCVD Risk Stratification mini-series, we focus on how to use these tools without overcomplicating primary prevention or getting lost in the details.

In this episode, we cover:

1. A practical, age-first framework for approaching primary prevention
2. How to use ASCVD risk calculators, risk enhancers, and coronary calcium score—and when not to
3. How to apply this framework consistently in real-world clinical practice

Bonus: Two quick cases—including one where guidelines don’t fit perfectly—and a short, actionable challenge you can start using immediately in clinic.

Want a companion resource? Download the free LipidCurious Starter Kit here
Questions or feedback? hello@lipidcurious.com

Join the Learn at Pinnacle app ⁠to earn FREE CE Credit for listening to this episode!

Disclaimer: This podcast is intended for educational purposes for clinicians and healthcare professionals. It does not provide medical advice, establish a physician–patient relationship, or replace individualized clinical judgment. The opinions expressed are those of the creator and do not represent the views of any affiliated institutions or organizations.

ASCVD risk stratification should be straightforward, but in real clinic time, it often isn’t. Multiple guidelines, limited time, overlapping categories, and nonstop competing priorities make lipid decisions feel harder than they need to be.

In Part 1 of this LipidCurious mini-series, I walk you through how I approach ASCVD risk BEFORE I ever open an ASCVD Risk calculator using a practical, repeatable framework grounded in the 2018 AHA/ACC guideline, with AACE, NLA, and ADA guidance layered in where it adds clarity.

In this episode, we cover:

1. Why ASCVD risk stratification matters
2. Where I start every single time (screening & what to check)
3. The THREE questions that guide most lipid decisions!

• Clinical ASCVD?
• LDL-C ≥190 mg/dL?
• Diabetes Mellitus age 40–75?

Bonus: You’ll also hear two quick cases that show how much you can decide without a calculator.

Want a companion resource? Download the free LipidCurious Starter Kit here
Questions or feedback? hello@lipidcurious.com

Disclaimer: This podcast is intended for educational purposes for clinicians and healthcare professionals. It does not provide medical advice, establish a physician–patient relationship, or replace individualized clinical judgment. The opinions expressed are those of the creator and do not represent the views of any affiliated institutions or organizations.

Hi everyone.

Happy New Year.

As the new year 2026 unfolds, I want to share three things in this episode.
1. What I hope LipidCurious continues to represent.
2. What I’m working on right now.
3. How I’m thinking about content on this platform moving forward.

I see LipidCurious as a shared journey between you and me. Let’s build it thoughtfully, together.

If you have ideas you’d like to share, I’d love to hear from you. This includes:

• Topics you'd like to be discussed in an episode
• Collaboration idea with groups or societies aligned with the mission of expanding cardiometabolic medicine.
• Mentors in the cardiometabolic space you’d love to see highlighted in an episode
• Cardiometabolic or lipid-focused training opportunities for our colleagues to explore.
• Non-clinical topic you want discussed in a future episode.

You can reach me anytime at hello@lipidcurious.com

Download the Free LipidCurious Starter Kit here

Disclaimer: This podcast is intended for educational purposes for clinicians and healthcare professionals. It does not provide medical advice, establish a physician–patient relationship, or replace individualized clinical judgment. The opinions expressed are those of the creator and do not represent the views of any affiliated institutions or organizations.

Inflammation!

We use the word all day in the clinic. We blame it for half the problems in medicine. Yet when you strip it down to its core, inflammation is one of the most misunderstood forces in cardiometabolic medicine.

In this episode of LipidCurious, we discuss

1. What is inflammation?

2. How do we measure it?

3. How do we treat it?

By the end, you’ll walk away with a sharper, cleaner understanding of inflammation’s role in cardiometabolic disease — and how to act on it in everyday practice.

And finally, a heartfelt wrap-up of Season 1, the journey behind building LipidCurious, and where this platform may go next.

Bonus: For the full collection of visuals across Season 1, visit the Podcast page.

Download the Free LipidCurious Starter Kit here

Questions or feedback? Reach out at hello@lipidcurious.com

Disclaimer: This podcast is for educational purposes only. It is NOT medical advice.

Most heart attacks don’t start with a clogged artery! They start with a microscopic storm — a small, invisible wound inside the artery wall.

That storm begins decades before symptoms, sometimes before high school. By the time someone hits their forties or fifties, the real question isn’t whether atherosclerosis has begun…It’s how far it’s already gone.

Let’s zoom in — literally inside the artery wall — and trace this disease from its very first spark.
From the moment an ApoB-containing particle sneaks beneath the endothelium…
To the slow, simmering inflammation that follows…
To the day a plaque finally stops being silent.

In this episode of LipidCurious, we’ll uncover

1. Anatomy & The Birth of an Atherosclerotic Plaque
2. Why Some Arteries Are More Prone to Atherosclerosis
3. Seeing, Treating, and Reversing Atherosclerosis

You’ll walk away seeing cholesterol numbers in a completely different light — not as abstract labs, but as a daily pressure on the artery wall.

By the end, you’ll understand why atherosclerosis is the slow burn beneath the surface — invisible for years, yet capable of erupting into the events we fear most.

Bonus: The Visual Guide for this episode is waiting for you — click here. For the full collection of visuals across episodes, visit the Podcast page.

Download the Free LipidCurious Starter Kit here

Questions or feedback? Reach out at hello@lipidcurious.com

Disclaimer: This podcast is for educational purposes only. It is NOT medical advice.

LDL may get all the blame — but there’s a darker twin hiding in the shadows.
Same cholesterol core. Same ApoB backbone.
But with one sinister twist: a sticky tail called apolipoprotein(a).
That extra piece transforms an ordinary LDL particle into something far more dangerous.

Meet Lipoprotein(a) — or Lp(a) — one of the strongest, most under-recognized genetic drivers of premature cardiovascular disease.
It’s pro-atherogenic, pro-thrombotic, and pro-inflammatory — a triple threat that can quietly turn even the healthiest-looking lipid panel into a ticking time bomb.

In this episode of LipidCurious, we’ll uncover

1. What is Lp(a)?

2. How and when to test for it?

3. What to do when Lp(a) is high?

We’ll walk through genetics, testing strategy, and real-world management — plus a glimpse into the promising therapies now in late-phase trials.
By the end, you’ll understand why Lp(a) is the ghost in the lipid story — invisible on a standard panel, but capable of haunting even the fittest hearts.

Bonus: The Visual Guide for this episode is waiting for you — click here. For the full collection of visuals across episodes, visit the Podcast page.

Download the Free LipidCurious Starter Kit here

Questions or feedback? Reach out at hello@lipidcurious.com

Disclaimer: This podcast is for educational purposes only. It is NOT medical advice.